APEX1 and neoplasm: This data indicates that both tumor and tumor-adjacent non-tumor tissue extracts have proteolytic-processing activity that cleaves recombinant APE1 in vitro in the absence, but not in the presence, of protease inhibitor cocktails (Figure 3A).